AbstractIntroduction: Nitrofurantoin (NFT) is a widely recognised pneumotoxin, with a range of clinico-radiological presentations reported in the literature.In this study we describe a series of n=26 patients with NFT-induced lung disease, analysing for features predicting resolution.Methods: Retrospective analysis of patient electronic records, laboratory and imaging results over a 10 year period.Results: N=25 patients had long-term NFT use, with n=1 patient presenting acutely following a 10...